title: Newly developed colorimetric drug screening assay for Bacillus anthracis.
authors.forename: Esther W
authors.initials: EW
authors.lastname: Barrow
authors.forename: Michelle Wright
authors.initials: MW
authors.lastname: Valderas
authors.forename: Philip C
authors.initials: PC
authors.lastname: Bourne
authors.forename: William W
authors.initials: WW
authors.lastname: Barrow
mesh_terms: D000881:Anthrax / Q000188:drug therapy; D001408:Bacillus anthracis / Q000187:drug effects* / Q000472:pathogenicity; D023482:Bioterrorism; D002939:Ciprofloxacin / Q000494:pharmacology; D003124:Colorimetry / Q000379:methods* / Q000592:standards; D004396:Coloring Agents; D004318:Doxycycline / Q000494:pharmacology; D024881:Drug Resistance, Bacterial; D006801:Humans; D066298:In Vitro Techniques; D008826:Microbial Sensitivity Tests / Q000379:methods* / Q000592:standards; D010078:Oxazines; D010406:Penicillins / Q000494:pharmacology; D012015:Reference Standards; D014966:Xanthenes
chemical_list: D004396:Coloring Agents; D010078:Oxazines; D010406:Penicillins; D014966:Xanthenes; C005843:resazurin; D002939:Ciprofloxacin; D004318:Doxycycline